The company's VC arm, NVentures, has made bets across the world of biotech startups
| CHARM Therapeutics | May. 2023 | N/A | $20M |
|---|---|---|---|
| Flywheel | Jun. 2023 | D | $54M |
| Genesis Therapeutics | Aug. 2023 | B | $200M |
| Superluminal Medicines | Aug. 2023 | Seed | $33M |
| Inceptive | Sep. 2023 | A | $100M |
| Generate:Biomedicines | Sep. 2023 | C | $273M |
| Evozyne | Sep. 2023 | B | $81M |
| Iambic Therapeutics | Oct. 2023 | B | $100M |
| Terray Therapeutics | Nov. 2023 | N/A | Undisclosed |
| Relation Therapeutics | Mar. 2024 | Seed | $35M |
